Clinically, drugs targeting Piezo1, such as Piezo1 agonists (e.g., Yoda1), can be used to reduce neuroinflammation, thereby protecting neurons from neurodegenerative diseases. This evidence concerns the gene PIEZO1 and neurodegenerative disease.